MedTrace Logo

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors

NCT03662204 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5133

Last updated 2022-09-01

No results posted yet for this study

Summary

The primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens to evaluate biomarkers associated with cancer for diagnostic assay development.

Conditions

Interventions

OTHER

Blood Sample Collection

Subjects participating in the study will have blood drawn at enrollment.

Sponsors & Collaborators

  • Exact Sciences Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-23
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03662204 on ClinicalTrials.gov